These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6573831)

  • 1. Cytologic findings of ascites from patients with ovarian dysgerminoma.
    Kashimura M; Tsukamoto N; Matsuyama T; Kashimura Y; Sugimori H; Taki I
    Acta Cytol; 1983; 27(1):59-62. PubMed ID: 6573831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic findings in peritoneal fluids from patients with ovarian serous adenocarcinoma.
    Kashimura M; Matsukuma K; Kamura T; Matsuyama T; Tsukamoto N
    Diagn Cytopathol; 1986; 2(1):13-6. PubMed ID: 3720477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysgerminoma of the ovary. Cytologic, histologic and electron microscopic study of a case.
    Hees K; de Jonge JP; von Kortzfleisch DH
    Acta Cytol; 1991; 35(3):341-4. PubMed ID: 1710406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the structural characteristics of ovarian dysgerminoma in its prognosis].
    Karseladze AI; Antoshechkina ET
    Vopr Onkol; 1985; 31(4):60-6. PubMed ID: 4002671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian dysgerminoma: MR and CT appearance.
    Tanaka YO; Kurosaki Y; Nishida M; Michishita N; Kuramoto K; Itai Y; Kubo T
    J Comput Assist Tomogr; 1994; 18(3):443-8. PubMed ID: 8188914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin and CD30 expression in dysgerminoma.
    Cossu-Rocca P; Jones TD; Roth LM; Eble JN; Zheng W; Karim FW; Cheng L
    Hum Pathol; 2006 Aug; 37(8):1015-21. PubMed ID: 16867864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late relapse of ovarian dysgerminoma: case report and literature review.
    Bekaii-Saab T; Einhorn LH; Williams SD
    Gynecol Oncol; 1999 Jan; 72(1):111-2. PubMed ID: 9889041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of ovarian dysgerminoma to yolk sac tumor: evidence for a histogenetic continuum.
    Parkash V; Carcangiu ML
    Mod Pathol; 1995 Oct; 8(8):881-7. PubMed ID: 8552580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature.
    Davidson B; Abeler VM
    Diagn Cytopathol; 2005 May; 32(5):307-9. PubMed ID: 15830366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of lymphocytic infiltration for the prognosis in dysgerminomas].
    Steffen R; Genton CY
    Schweiz Med Wochenschr; 1980 Jun; 110(26):1013-9. PubMed ID: 7423140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems on histopathological diagnosis of malignant ovarian tumors].
    Namiki T
    Rinsho Byori; 1985 Aug; 33(8):917-23. PubMed ID: 3908750
    [No Abstract]   [Full Text] [Related]  

  • 12. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
    Graves LE; Ariztia EV; Navari JR; Matzel HJ; Stack MS; Fishman DA
    Cancer Res; 2004 Oct; 64(19):7045-9. PubMed ID: 15466198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 21 associated with ovarian dysgerminoma.
    Smucker JD; Roth LM; Sutton GP; Hurteau JA
    Gynecol Oncol; 1999 Sep; 74(3):512-4. PubMed ID: 10479522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadoblastoma with contralateral dysgerminoma in a young female--a case report.
    Jadhav MN; Yelikar BR; Karigoudar M
    Indian J Pathol Microbiol; 2006 Apr; 49(2):274-6. PubMed ID: 16933739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations.
    Katz E; Skorecki K; Tzukerman M
    Clin Cancer Res; 2009 Jan; 15(1):70-80. PubMed ID: 19118034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic presentation of ovarian adenosquamous carcinoma in ascitic fluid. A case report.
    Tsukamoto N; Matsukuma K; Daimaru Y; Ota M
    Acta Cytol; 1984; 28(6):703-5. PubMed ID: 6594883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.
    Gordon A; Lipton D; Woodruff JD
    Obstet Gynecol; 1981 Oct; 58(4):497-504. PubMed ID: 7279343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.
    Yang W; Toffa SE; Lohn JW; Seifalian AM; Winslet MC
    Gynecol Oncol; 2005 Feb; 96(2):430-8. PubMed ID: 15661232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytodiagnosis of ovarian cancer--usefulness of peritoneal washings in histological diagnosis].
    Yoh S; Nishida T; Tanaka H; Tasaki T; Matsukuma T; Kawano S; Abe T; Nishida T; Yakushiji M; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):30-6. PubMed ID: 6699447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.